Delivery Order SPE2DB22D2005-SPE2DB24FJGT8
- Not listed
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $13,309.59 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of 4566614119 - Cephalexin 250 mg/5 ml suspension, 200 ml, a generic antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $8,129.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, to support military and government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,543.56 contract is for the delivery of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, to support military treatment facilities and other federal medical institutions. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $45,515.02 firm fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension (200 ml) to support the medical needs of military and veterans' healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,780.23, is for the delivery of Cephalexin 250 mg/5 ml suspension in 100 ml containers. This is a firm fixed-price delivery order contract with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,725.49 firm fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of September 27, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Cephalexin 250 mg/5 ml suspension, a generic antibiotic pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $1,792.49 and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,110.44, is for the delivery of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $7,749.93 Firm Fixed Price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,328.58 firm fixed-price delivery order is for the supply of Cephalexin 250 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 with the DLA Troop Support Medical. The IDC serves as the primary vehicle for...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJGT8Delivery Order
This contract award, valued at $38,784.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical distributor, plays a critical role in supplying essential medical commodities to various federal government agencies, particularly the military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.8k | 1/23/24 |